Opko Health (OPK) Income from Continuing Operations (2010 - 2026)
Opko Health's (OPK) quarterly Income from Continuing Operations came in at -$8.4 million in Q2 2026, up 94.33% on a YoY basis from -$4.3 million in Q2 2025, and up 84.66% quarter-over-quarter from -$54.8 million in Q1 2026.
Opko Health (OPK) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Income from Continuing Operations for 17 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations rose 94.33% year-over-year to -$8.4 million; the trailing twelve-month figure through Jun 2026 stood at -$37.9 million (up 86.63% YoY), and the FY2025 full-year result was -$190.7 million, down 258.37% from the prior year.
- Income from Continuing Operations improved to -$8.4 million in Q2 2026 per OPK's latest filing, from -$54.8 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $24.9 million in Q3 2024 and bottomed at -$148.4 million in Q2 2025.
- Historically, Income from Continuing Operations has averaged -$54.1 million across 5 years, with a median of -$66.5 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations plunged 528.96% in 2022, then surged 129.48% in 2024.
- Over 5 years, Income from Continuing Operations stood at -$85.2 million in 2022, then gained by 21.98% to -$66.5 million in 2023, then soared by 137.45% to $24.9 million in 2024, then tumbled by 84.98% to $3.7 million in 2025, then plunged by 325.09% to -$8.4 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered -$8.4 million, -$54.8 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -246.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 3.32 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 2.16 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | -644.37 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 237.01 Mn |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | -8.42 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.42 Mn |
| Mar 31, 2026 | -54.85 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 21.63 Mn |
| Jun 30, 2025 | -148.44 Mn |
| Mar 31, 2025 | -67.60 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | -92.14 Mn |
| Mar 31, 2024 | -81.83 Mn |
| Dec 31, 2023 | -66.48 Mn |
| Sep 30, 2023 | -84.45 Mn |
| Jun 30, 2023 | -19.60 Mn |
| Mar 31, 2023 | -18.23 Mn |
| Dec 31, 2022 | -85.21 Mn |
| Sep 30, 2022 | -86.05 Mn |
| Jun 30, 2022 | -101.38 Mn |
| Mar 31, 2022 | -55.38 Mn |
| Dec 31, 2021 | -73.31 Mn |
| Sep 30, 2021 | 28.79 Mn |
| Jun 30, 2021 | -16.12 Mn |
Opko Health Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=OPK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();